Reaction
Blood Immunoglobulin A Increased reporting signals
As of the last recalculation, Blood Immunoglobulin A Increased appears in 529 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 112.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 22 | 112.7 | 113.1 |
| Esomeprazole Magnesium Capsule, Delayed Release | 32 | 92.3 | 92.5 |
| Esomeprazole Magnesium Delayed Release Capsules | 32 | 92.3 | 92.5 |
| Esomeprazole Magnesium Dihydrate | 32 | 91.9 | 92.1 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 40 | 79.6 | 79.8 |
| Cetirizine Hydrochloride Allergy | 46 | 65.4 | 65.5 |
| Cetirizine Hydrochloride Tablets | 46 | 65.4 | 65.4 |
| Vitamin E | 41 | 55.5 | 55.6 |
| Tapentadol Hydrochloride | 25 | 30.8 | 30.8 |
| Duloxetine | 49 | 30.4 | 30.4 |
| Cetirizine | 53 | 29.8 | 29.8 |
| Posaconazole Delayed-Release | 7 | 25.4 | 25.4 |
| Rifampicin | 6 | 23.6 | 23.6 |
| Daratumumab | 21 | 21.5 | 21.5 |
| Pyrazinamide | 5 | 21.1 | 21.1 |
| Ixazomib | 13 | 18.2 | 18.2 |
| Thalidomide | 16 | 17.7 | 17.7 |
| Azacitidine For | 8 | 17.6 | 17.6 |
| Carfilzomib | 11 | 15.6 | 15.6 |
| Azacitidine | 9 | 12.1 | 12.1 |
| Pomalidomide | 21 | 8.3 | 8.3 |
| Somatropin | 13 | 7.1 | 7.1 |